Skip to content
FIND A HEALTH VALLEY ACTOR

“Bringing meaning back to the healthcare professionals”

Prof. Antoine Geissbuhler BioAlps President

Appointed Dean of the Faculty of Medicine at the University of Geneva, Professor Antoine Geissbuhler, is also Director of Teaching and Research at the HUG, and BioAlps President. In an interview to Pulsation Magazine, he has set himself the ambitious goal of meeting the many challenges facing medical education today.     What would you…

Read More

Multiwave Technologies partners with Aix Marseille University

Multiwave technologies

Multiwave Technologies brings to market a portable MRI device powered by metamaterial technologies and AI software. ​ The partnership includes joint research and the financing of 5 portable MRI units to be deployed in medical and sport labs across Aix-Marseille University sites for research purposes.     Developing a new generation of MRI equipment… This is the aim of…

Read More

Monitor your blood pressure with OptiBP, a Biospectal application

BioSpectal

Patients can measure their blood pressure in 30 seconds by placing their fingertip on the camera lens of a smartphone.     “Finally, measuring blood pressure anywhere and anytime has become so easy that dramatically more people will be able to manage their cardiovascular disease better from now on,” comments Jens Krauss, Head of the…

Read More

BioLizard chooses Biopôle for its Swiss subsidiary

BioLizard

BioLizard is a Belgian bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry.     Liesbeth Ceelen, PhD, CEO of BioLizard, said: “We aim to meet the need for expertise and tools for digital transformation of biotech companies, including for AI-enabled, user-friendly software and data infrastructure.…

Read More

Oryl Photonics raises CHF 830,000 in seed funding

Oryl Photonics

The Vaud-based startup announces the successful conclusion of a CHF 830,000 seed fundraising. The round is backed by Swiss investors, including CADFEM International AG, S2S Ventures and several business angels.     This is a significant achievement for Oryl Photonics, a company pioneering the development of highly efficient solubility measurement for pharmaceutical and life science…

Read More

CSEM Inventor Award granted to spaceCoder

CSEM Inventor Award

Shedding Light on Precision: CSEM spaceCoder technology is a game changer in the field of precision measurement     In the realm of scientific innovation, where light illuminates, shadows also cast opportunities for advancement. Researchers at CSEM (Centre Suisse d’Electronique et de Microtechnique) have ingeniously harnessed this principle with their groundbreaking “spaceCoder” technology, heralding a…

Read More

Successful € 5 Million Capital Increase for GeNeuro

GeNeuro

GeNeuro, a Geneva-based biopharmaceutical company focusing on treatments for neurodegenerative and autoimmune diseases, including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and severe neuropsychiatric consequences of COVID-19 (post-COVID), has successfully completed a €5 million capital increase.     The increase involved a private placement of 4,666,901 new GeNeuro ordinary bearer shares for specialized and strategic…

Read More

Nicolas Durand appointed Director of the Campus Biotech Foundation in Geneva

Nicolas Durand 2

Dr Nicolas Durand will step down from his CEO role at Abionic on 29 February to be at the steering wheel of the innovation centre from 1 March 2024     The Foundation Campus Biotech announced the appointment of its new Director, Dr Nicolas Durand. “With an extensive background in nanotechnologies applied to life sciences,…

Read More

Debiopharm and TransCode Therapeutics Collaborate to Develop Targeted Nucleic Acid Therapeutics for Cancer

Debiopharm

TransCode Therapeutics is a RNA oncology company based in the United States committed to more effectively treating cancer using RNA therapeutics. Debiopharm, a privately-owned Swiss-based, global biopharmaceutical company, aims to establish tomorrow’s standard-of-care to cure cancer and infectious diseases.     The collaboration will explore combining TransCode’s proprietary TTX delivery platform with Debiopharm’s expertise in…

Read More

Vaud: a CHF 90 Million plan to tackle the shortage of healthcare staff

InvestPro Programme Vaud

The Vaud State Council has drawn up a CHF 90 Million “far-reaching plan” to meet the challenges presented by the shortage of healthcare and nursing staff: the InvestPro programme will be based on training, promotion of the professions in the field and retention.     Demographic change, an ageing population and an increase in chronic…

Read More